59 North Communications
  • 59 North Communications
  • Quotes
  • Share:
  • Subscribe:
  • news.cision.com/
  • 59 North Communications/
  • Ilya Pharma publishes data on potent bacterial killing effect by ILP100 on totally resistant bacterial pathogens from Ukrainian war victims/
  • Evelina Vågesjö CEO 1

Evelina Vågesjö CEO 1

Tue, Apr 01, 2025 15:10 CET

Low resolution

Medium resolution

Original resolution

Subscribe

Related Releases

Ilya Pharma receives Rare Pediatric Disease Designation from the U.S. FDA for emilimogene sigulactibac for the treatment of skin wounds in SAVI patients Wed, Sep 11, 2024 14:57 CET
Ilya Pharma extends global patent coverage for ILP100 for the treatment of diseases of skin and mucosa in humans and animals Mon, May 23, 2022 09:50 CET
Ilya Pharma announces FDA clearance of IND for first-in-class ILP100-Topical immunotherapy treatment of surgical wounds in patients with prediabetes, diabetes and obesity Wed, May 04, 2022 08:30 CET
©Cision
Privacy statement | Cookies | About | Content Policy | Contact    Cision
©Cision Privacy statement Cookies About Content Policy Contact

   Cision